chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Angina Narrative: Two mins post vaccine Employee complained of SOB and chest tightness/pain that lasted for 60 seconds. Vital signs stable. 125/83, 98.2, 64, 16. Employee assessed by MD and per MD no further treatment needed.
States she had severe diarrhea 11/14/20 to 11/16/20
Post vax, the pt developed cellulitis. The reporter indicated that 4 patients experienced this event; however, they are not presently identifiable.
DEMAND ISCHEMIA 12/5/2022 ASTHMA, UNSPECIFIED ACUTE RESPIRATORY FAILURE 11/29/2022 ASTHMA, UNSPECIFIED ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2022 ASTHMA, UNSPECIFIED CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/9/2023 ASTHMA, UNSPECIFIED HYPOXEMIA 1/4/2023 ASTHMA, UNSPECIFIED DEMAND ISCHEMIA 12/5/2022 HYPERKALEMIA ACUTE RESPIRATORY FAILURE 11/29/2022 HYPERKALEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2022 HYPERKALEMIA CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/9/2023 HYPERKALEMIA HYPOXEMIA 1/4/2023 HYPERKALEMIA DEMAND ISCHEMIA 12/5/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ACUTE RESPIRATORY FAILURE 11/29/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/9/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED HYPOXEMIA 1/4/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED DEMAND ISCHEMIA 12/5/2022 DM 2 W PERIPHERAL VASCULAR DISEASE ACUTE RESPIRATORY FAILURE 11/29/2022 DM 2 W PERIPHERAL VASCULAR DISEASE ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2022 DM 2 W PERIPHERAL VASCULAR DISEASE CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/9/2023 DM 2 W PERIPHERAL VASCULAR DISEASE HYPOXEMIA 1/4/2023 DM 2 W PERIPHERAL VASCULAR DISEASE DEMAND ISCHEMIA 12/5/2022 AFTERCARE FOR MUSCULOSKELETAL SYSTEM SURGERY ACUTE RESPIRATORY FAILURE 11/29/2022 AFTERCARE FOR MUSCULOSKELETAL SYSTEM SURGERY ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2022 AFTERCARE FOR MUSCULOSKELETAL SYSTEM SURGERY CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/9/2023 AFTERCARE FOR MUSCULOSKELETAL SYSTEM SURGERY HYPOXEMIA 1/4/2023 AFTERCARE FOR MUSCULOSKELETAL SYSTEM SURGERY DEMAND ISCHEMIA 12/5/2022 NONTRAUMATIC ACUTE KIDNEY INJURY  ACUTE RESPIRATORY FAILURE 11/29/2022 NONTRAUMATIC ACUTE KIDNEY INJURY ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2022 NONTRAUMATIC ACUTE KIDNEY INJURY CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/9/2023 NONTRAUMATIC ACUTE KIDNEY INJURY HYPOXEMIA 1/4/2023 NONTRAUMATIC ACUTE KIDNEY INJURY
rash in different parts of his body / rash on the right arm; first dose / given on January 2020 / second dose / end of September; This case was reported by a nurse via call center representative and described the occurrence of generalized rash in a 90-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (received 1st dose in Januray 2020).   In September 2020, the patient received the 2nd dose of Shingrix. In September 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced generalized rash. On an unknown date, the outcome of the generalized rash was not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the generalized rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose of shingrix and 2 weeks after experienced rash on arm and on all parts of body. The patient received 2nd dose, more than the recommended interval, which led to lengthening of vaccination schedule. The patient did not experience symptoms after 1st dose of shingrix. The reporter consented to follow up.
Rash on upper arm that has spread from the injection site to her elbow. It started the day after the vaccine and has grown steadily. She reports it is mildly swollen and itchy. She went to her PCP on 4/23, who advised her to take a steroid pack if it continues to get worse.
low back pain; fever; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (low back pain), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No relevant medical history was reported.  Concomitant products included VITAMIN D NOS for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced BACK PAIN (low back pain), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, BACK PAIN (low back pain), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report was received from the consumer (patient father) refers to 18 year old female patient. The patient's pertinent medical history included allergy to amoxicillin. On 22-MAY-2014 the patient was vaccinated with GARDASIL first dose, intramuscular in the left arm (dose and frequency were unspecified by the reporter). No concomitant medications were reported. On 22-MAY-2014, after receiving GARDASIL, the patient was tired and slept for the entire day. On an unknown date in May 2014, the patient experienced discomfort in her rib areas, continued to feel lethargic and bedridden (disability). Approximately on an unknown date in 2014 (4-5 days before in June 2014 when she was scheduled to receive her second dose of GARDASIL), the patient collapsed. On an unknown date in May 2014, the patient developed swollen lymph nodes in her pelvic area. On an unknown date, the patient sought medical attention at the physician's office. The patient did not receive any treatment. On an unknown date in May 2014, the patient underwent some blood work. The outcome of the events was reported that the patient was still experiencing the adverse events and has not recovered. The physician did not believe that the events to be related to the suspect therapy, however the patient felt the events to be related to the suspect therapy. The event bedridden was considered serious (disability). Additional information has been requested.
Pt states that after 3rd dose of Anthrax he dvlped back pain. Pt states that he went to physical therapy & during the course he started dvlping pain in his left leg. Pt states he had gotten better around 6/99,but relapsed after his 4th dose
Chills; night sweats; extreme pain in both legs; pain in the upper hip joint; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9262), via an unspecified route of administration in left arm on 17Feb2021 10:45 (at the age of 66-years-old) as dose 1, single for COVID-19 immunization. Medical history included iodine allergy. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks nor any other medications within two weeks prior. The patient experienced chills, night sweats, extreme pain in both legs and pain in the upper hip joint on 17Feb2021 22:00. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Night sweats was resolved after 2 days, pain in the upper hip joint was resolved on 18Feb2021. Outcome of Chills and extreme pain in both legs was resolved on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Had very mild Tinnitus prior to vaccine after second vaccine Tinnitus got significantly worse and has not gotten any better.  I also had vertigo after vaccine for three weeks which I had never had before.
Spotty rash formed on her entire body by the evening of the same day. Still has some rash remaining.
Chills, body aches, headache, and fatigue starting about 12 hours after the vaccine. The chills resolved quickly (within 24 hours), but the headache, body aches, and fatigue have continued through today (one week after receiving the vaccine).  Ibuprofen has been the only treatment.  The symptoms temporarily improve after taking ibuprofen and then return.  I have not been able to exercise since receiving the vaccine and I missed one day of work (1/12/21). I have no history of adverse reactions to any other vaccines and I had no adverse reaction to the first dose. I work as a Clinical Nurse Leader on a Critical Care floor.  One of my directors suggested I submit a VAERS.
No reaction until Day 3 after injection on October 29th.  Felt some chest "fluttering", slight weakness.   Nothing for the next 4-5 days.  Then chest fluttering, SOB, slight unsteadiness, generally didn't "feel right".  I awoke at 1:30 AM on November 9th because of the chest fluttering (fibrillation), SOB and feeling that "this isn't AOK!!  My husband drove me to the ER.  I was there about 7 hours. I was released with an RX for Metoprolol  25 mg--1/2 tablet twice daily with meals.
This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no known allergies and was not pregnant at the time of reporting. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855791, expiry: 11-APR-2022) dose was not reported, administered on 01-APR-2022 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2022, the patient experienced mental fogginess, body aches/achiness, sharp pain behind both eyes, blurry peripheral vision on both eyes/more predominant on the left eye, and headache. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from mental fogginess on 03-APR-2022, and was recovering from headache, body aches/achiness, sharp pain behind both eyes, and blurry peripheral vision on both eyes/more predominant on the left eye. This report was non-serious. Sender's Comments: V0:  Medical assessment comment not required as per standard procedure as the case assessed as non-serious.
Symptoms: Rash and Erythema Multiform. Treatment: Diphenhydramine 25 mg t.i.d., naproxen 500 mg b.i.d.
Patient complains of pain in right arm where flu shot was given. Patient stated symptoms started the day after vaccination and is still ongoing. Pain/discomfort is in right arm and hurts when moving/rotating. Pain begins on the top of arm and extends to halfway down her upper arm (in between shoulder and elbow). Patient reports no pain on left arm from PREVNAR vaccine. Patient has tried icing the arm as well as taking Ibuprofen with little relief. Patient will be consulting with PCP to discuss reaction and further treatment options.
Patient received COVID vaccine at 0939, during observation period reported tingling of tongue and lips approx. at  1010.  Benadryl 25mg by mouth administered. Patient continued to be monitored for additional 1hr.  Benadryl improved symptoms, patient denied SOB and remained calm throughout.  Swelling and tingling improved. Patient went back to work in hospital where received vaccine.  Patient confident in monitoring return of symptoms while on site working.  Patient reports list of allergies and has dealt with symptoms of allergic reactions before.  This RN checked on patient after vaccine clinic and residual tingling remained but otherwise patient "felt good".    Called patient at 1707 to follow up.  Patient reports minor residual burning on lip otherwise other symptoms resolved.  Continues to denies difficulty breathing, " I feel fine"
shooting pain in my neck on the left side; Chest pains which felt like a heart spasm or flutter; Chest pains which felt like a heart spasm or flutter; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 34-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EP7533, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 02Apr2021 at 14:45 pm (age at vaccination was 34 years) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications the patient received within 2 weeks of vaccination included spironolactone, drospirenone, ethinylestradiol (SYEDA) and ibuprofen all taken for an unspecified indication. The facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021, three days after receiving the first dose, the patient had chest pains which felt like a heart spasm or flutter. On an unspecified date, the patient also experienced a shooting pain in her neck on the left side. These symptoms lasted off and on for about 2 weeks. She saw her doctor but they were unable to diagnose it. EKG (electrocardiogram) and carotid ultrasound were normal on an unspecified date in Apr2021. The pains subsided about 18 days after her vaccine appointment. The adverse event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse events. The device date was reported as 10May2021. The case was reported as non-serious. The outcome of the events was resolved on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected
Received MMR vaccination and upon checking out complained of "lightheadedness" and passed out, head hitting floor. Revived immediately, pale and oriented X 3. Sat up in 2 minutes then placed in wheelchair and taken to exam room table. After 45 minutes, pt left with no complaint of dizziness, lightheadedness. Mom picked her up. BP 100/60, P-48; R-16 and at 14:45, BP-108/58; P-60; R-16. She was given sprite to drink and pt states "I have passed out before when I got a shot at the MD's office when he cut out an ingrown toenail". Some color starting to return. At 15:00, client states again fells lightheaded, ears feel hot and looks pale again. BP 90/60, P-48, R-20. Exam table positioned flat and a wet rag told to back of neck and forehead. At 15:15, pt states "I feel better"; color returning; BP-102/60, P-52 and R-16. At 15:30, family her to get her and BP-100/60; P-56; R-16. Client walked to car and had no other problems.
redness on arm; Covid-arm; Rash; Soreness on arm; Weird saliva reaction in her mouth; Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine; Ended up sleeping for 5 hours; This spontaneous case was reported by a consumer and describes the occurrence of SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine), SOMNOLENCE (Ended up sleeping for 5 hours), ERYTHEMA (redness on arm) and VACCINATION COMPLICATION (Covid-arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Ulcerative colitis (Received remicade infusions every 6 weeks) in 1990. Concurrent medical conditions included Penicillin allergy. Concomitant products included INFLIXIMAB (REMICADE), AZATHIOPRINE (IMURAN [AZATHIOPRINE]), LISINOPRIL, FISH OIL (FISH OIL OMEGA 3), PANTOPRAZOLE and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication, ATORVASTATIN CALCIUM (LIPITOR), HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE & HCTZ) and BUPROPION HCL.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine) and SOMNOLENCE (Ended up sleeping for 5 hours). On an unknown date, the patient experienced ERYTHEMA (redness on arm), VACCINATION COMPLICATION (Covid-arm), RASH (Rash) and MYALGIA (Soreness on arm). At the time of the report, SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine), SOMNOLENCE (Ended up sleeping for 5 hours), ERYTHEMA (redness on arm), VACCINATION COMPLICATION (Covid-arm), RASH (Rash) and MYALGIA (Soreness on arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-035860 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Added new reporter details, Allery (penicillin), concomitant medications (Lipitor, Triamterene-HCTZ, Bupropion HCL) and added new events.
2nd dose given < 25 days from 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given < 25 days from 1st dose) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given < 25 days from 1st dose). On 30-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given < 25 days from 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment details were reported.
Ringing ears approx. 9 hours post-vaccination lasting about 30-45 minutes
Patient felt dizzy, short of breath, reported that she vomited.  Also reported that arm was swollen, red, and warm. She called the pharmacy and was told to take Benadryl and to report to the emergency room if symptoms worsened or persisted.  She was called again the next day (10/14/2010).  She reported that she did not go to the ER but that the Benadryl did help with the dizziness, vomiting, and shortness of breath.  She reported that her arm was still swollen, red, and warm, but the area was smaller than the night before.  She reported that she had taken Tylenol to help her arm.  She was counseled to try ibuprofen instead to help with the inflammation and that if symptoms worsened or persisted to seek medical attention.
5-7 days after injection Rash,  altered mental statues, shortness of breath
Nausea approx. 24 hours. Swelling of upper arm with extreme pain for approx. 9 days. Extreme weakness.
Rash at back of arm where vaccine was given.  Also, I feel itchy all over my body.  Especially scalp and face.
This spontaneous report was received from a registered nurse referring to a patient of currently 1 year age and the patient was vaccinated with improperly stored dose of VARIVAX (Merck) with lot # L034368, expiry date 08-SEP-2017; dose, route of administration and anatomical location not reported). The doses of VARIVAX (Merck) underwent temperature excursion: 14.7F for 2 hours and 15 minutes. There were no previous temperature excursions. No symptoms were reported. NO product quality complaint (PQC) was involved. No further information provided. This is one of several reports from the same reporter. Additional information has been requested.
Patient with right thigh redness/swelling, tender with indistant borders. Patch 10cm wrapping around the lateral thigh. Vaccine administered 1/13/03; reported to MD 1/15/03.
<48 hours following 2nd vaccine, altered mental status leading to hospitalization and dx of encephalitis. symptoms resolved completely within 12 hours
Chills, Fever,  redness, pain,  multiple swelling by injection site.
Woke during night with numbness lt. arm, tingling in hand and chest discomfort similar to that 10 years ago - "Dr thought flu virus settled around heart" - ADVIL helped nurse at Dr's office suggested nerve possibly touched by needle and to take TYLENOL prn - Client agreed and has no other complaints.
Severe disorientation and mental confusion with difficulty communicating and preforming routine task: lasting 72 hours
The pt experienced nausea, pallor, twitching of the arm which moved to the entire body. Epinephrine was given and 911 called, airway was in place IV started. The pt was taken to hospital. She was conscious at this time.
Flu like symptoms; Fever; Chills; Feeling achy; This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included fibromyalgia.   In September 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced influenza-like symptoms, fever, chills and general body pain. On an unknown date, the outcome of the influenza-like symptoms, fever, chills and general body pain were unknown.   It was unknown if the reporter considered the influenza-like symptoms, fever, chills and general body pain to be related to Shingrix.  Additional details were received as follows: The patient received 1st Shingrix dose 6 months ago and had flu like symptoms consisting of fever, chills, and feeling achy.  Pharmacist provided limited information.  Pharmacist had another call coming in and states she may call back to provide more information if patient consents.